相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
Thomas Bieber
NATURE REVIEWS DRUG DISCOVERY (2022)
Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
Ecem Bostan et al.
ARCHIVES OF RHEUMATOLOGY (2022)
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
M. C. Fargnoli et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2021)
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Ioana Agache et al.
ALLERGY (2021)
Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment
M. Napolitano et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
TH cell diversity and response to dupilumab in patients with atopic dermatitis
Coline Trichot et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Atopic dermatitis displays stable and dynamic skin transcriptome signatures
Lena Mobus et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis
Doreen Siegels et al.
ALLERGY (2021)
Treatment-emergent adverse events in dupilumab-treated patients with allergic diseases: A meta-analysis
Xiaohong Chen et al.
ALLERGY (2021)
Incidence and risk factors for dupilumab associated ocular adverse events: a real-life prospective study
A. T. Touhouche et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)
A. Wollenberg et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Dupilumab-Associated Ocular Surface Disease: Clinical Characteristics, Treatment, and Follow-Up
Austin Bohner et al.
CORNEA (2021)
Dupilumab treatment of atopic dermatitis leading to successful treatment of alopecia universalis: A Japanese case report
Jun Muto et al.
JOURNAL OF DERMATOLOGY (2021)
Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis
Justine Cheng et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sezary syndrome
O. Steck et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis
Roselie Achten et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
Ashish Bansal et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)
Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular events
Alyssa M. Thompson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Facial and neck erythema associated with dupilumab treatment: A systematic review
Christine E. Jo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
De novo psoriasis in atopic dermatitis patients treated with dupilumab: a retrospective cohort
L. Jaulent et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy
Charlie Bridgewood et al.
RHEUMATOLOGY (2021)
Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade
Christine Bangert et al.
SCIENCE IMMUNOLOGY (2021)
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Ioana Agache et al.
ALLERGY (2021)
Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
Reiko Kageyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis
Daphne S. Bakker et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report
F. N. Mirza et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Dupilumab-induced psoriasis and alopecia areata: Case report and review of the literature
J. Beaziz et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2021)
Characterization of the Oral and Gut Microbiota in Patients with Psoriatic Diseases: A Systematic Review
Tanja Todberg et al.
ACTA DERMATO-VENEREOLOGICA (2021)
Serum IgE reduction and paradoxical eosinophilia associated with allergic conjunctivitis after dupilumab therapy
Ayaka Kimura et al.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION (2021)
Facial and neck erythema associated with dupilumab treatment: A review
Christine E. Jo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Acute arthritis and arthralgia as an adverse drug reaction to dupilumab
L. E. M. de Wijs et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis
A. N. Voorberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis A Phase 3 Randomized Clinical Trial
Eric L. Simpson et al.
JAMA DERMATOLOGY (2020)
Dupilumab-Induced Bilateral Cicatricial Ectropion in Real Life
Eustachio Nettis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series
L. E. M. de Wijs et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
The effectiveness of dupilumab in patients with alopecia areata who have atopic dermatitis: a case series of seven patients
K. Harada et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
G. Caldarola et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano et al.
GASTROENTEROLOGY (2020)
Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis: A Multicenter Real-Life Experience
E. Nettis et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2020)
Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of immunoglobulin E and thymus and activation-regulated chemokine but not clinical severity in a real-world setting
Hideaki Uchida et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented?
Helen A. Brough et al.
ALLERGY (2020)
Rapid hair regrowth induced by dupilumab in a patient affected by alopecia totalis of 28 years' duration: Clinical and dermoscopic features
Graziella Babino et al.
DERMATOLOGIC THERAPY (2020)
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis A Phase 2b Randomized Clinical Trial
Emma Guttman-Yassky et al.
JAMA DERMATOLOGY (2020)
Incidence of Conjunctivitis and Other Ocular Surface Disorders in Patients with Long-Term Dupilumab Use
Christine E. Jo et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2020)
Dupilumab-Associated Mucin Deficiency (DAMD)
Brad P. Barnett et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2020)
Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients
Maria L. Espinosa et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
An asthmatic case of psoriasiform eruption caused by administration of dupilumab
Takashi Matsuda et al.
ALLERGOLOGY INTERNATIONAL (2020)
Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis
Tamara Quint et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Psoriatic Plaques After Initiation of Dupilumab Therapy
Taryn M. DeGrazia et al.
DERMATITIS (2020)
Psoriasis onset under dupilumab treatment in two patients affected by atopic dermatitis and one patient affected by alopecia areata: Clinical and dermoscopic patterns
Ilenia D'Ambra et al.
DERMATOLOGIC THERAPY (2020)
Progression of mycosis fungoides after treatment with dupilumab: A case report
Denis Miyashiro et al.
DERMATOLOGIC THERAPY (2020)
Dupilumab-induced psoriatic erythroderma with characteristic cytokine and antimicrobial peptide expression pattern in a patient with long standing atopic dermatitis
Thilo Gambichler et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2020)
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers
Helen He et al.
FRONTIERS IN IMMUNOLOGY (2020)
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Characterizing dupilumab facial redness in children and adolescents: A single-institution retrospective chart review
Sonal Muzumdar et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
Cary D. Austin et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Long-standing Dermatitis Treated With Dupilumab With Subsequent Progression to Cutaneous T-cell Lymphoma
L. Claire Hollins et al.
CUTIS (2020)
Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
John E. Call et al.
CLINICAL CASE REPORTS (2020)
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Sarah Faiz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis
Ken Fukuda et al.
ALLERGOLOGY INTERNATIONAL (2019)
Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series
Z. N. Willsmore et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Conjunctivitis in dupilumab clinical trials
B. Akinlade et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab
Gefei Alex Zhu et al.
JAMA DERMATOLOGY (2019)
A case of guttate psoriasis during treatment with dupilumab
Niccolo Gori et al.
DERMATOLOGIC THERAPY (2019)
Dupilumab and alopecia: A Janus effect
Cataldo Patruno et al.
DERMATOLOGIC THERAPY (2019)
Dupilumab Ocular Surface Disease Occurs Predominantly in Patients receiving Dupilumab for Atopic Dermatitis: A Multi-institution Retrospective Chart Review
Reid A. Waldman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
A case of chronic eosinophilic pneumonia in a patient treated with dupilumab
Francesco Menzella et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2019)
Development or Exacerbation of Head and Neck Dermatitis in Patients Treated for Atopic Dermatitis With Dupilumab
Angele Soria et al.
JAMA DERMATOLOGY (2019)
Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series
Maddalena Napolitano et al.
DERMATOLOGIC THERAPY (2019)
A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
Gaurav Agnihotri et al.
DRUGS IN R&D (2019)
Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis
D. S. Bakker et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice
M. Tauber et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Dermatitis and alopecia in a patient treated with dupilumab: a new adverse effect?
I. Salguero-Fernandez et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2019)
New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab
Saskia Herz et al.
DERMATOLOGIC THERAPY (2019)
Simultaneous effectiveness of dupilumab in atopic dermatitis and alopecia areata in two patients
Laine Ludriksone et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2019)
Frontiers in alopecia areata pathobiology research
Amos Gilhar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Dupilumab-Induced Follicular Conjunctivitis
Elizabeth Shen et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Dupilumab side effect in a patient with atopic dermatitis: a case report study
Sakhar S. Albader et al.
BIOLOGICS-TARGETS & THERAPY (2019)
Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis
Maya L. M. Yamane et al.
ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY (2019)
Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis
Cindy Barbarin et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2019)
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
Adrien Maudinet et al.
OPHTHALMOLOGY AND THERAPY (2019)
Psoriasis-like Dermatitis Developing in a Patient with Atopic Dermatitis Treated with Dupilumab
Molly Stout et al.
DERMATITIS (2019)
Alopecia Areata After Treatment with Dupilumab
Shiva Yazdanyar et al.
DERMATITIS (2019)
Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?
J. P. Thyssen
BRITISH JOURNAL OF DERMATOLOGY (2018)
Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata
A. -S. Darrigade et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFE)
M. de Bruin-Weller et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
Andreas Wollenberg et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Context-Dependent Regulation of Conjunctival Goblet Cell Function by Allergic Mediators
Laura Garcia-Posadas et al.
SCIENTIFIC REPORTS (2018)
Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
Manuel Jorge Rial Prado
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2018)
Hair Regrowth in a Patient With Long-standing Alopecia Totalis and Atopic Dermatitis Treated With Dupilumab
Lauren R. Penzi et al.
JAMA DERMATOLOGY (2018)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-) in patients with alopecia areata: association with clinical type and severity
Mona A. Atwa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Targeting key proximal drivers of type 2 inflammation in disease
Namita A. Gandhi et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis
Laureline Legendre et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
Emmanuella Guenova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Jennifer D. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata
Shigeki Inui et al.
JOURNAL OF DERMATOLOGY (2013)
Tear cytokines and chemokines in patients with Demodex blepharitis
Jee Taek Kim et al.
CYTOKINE (2011)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
分享论文
